WHAT IS THE CDDF?
The Cancer Drug Development Forum (CDDF) is a non-profit organisation registered in Belgium that provides a neutral platform to stimulate interaction between stakeholders involved in cancer drug development.
The CDDF’s mission is to provide a trusted space for all stakeholders in cancer drug development to facilitate dialogue, debate, and communication, fostering innovation to accelerate access to new (or the best) treatments for all patients.
Its integrative approach brings together leading voices from academia, the pharmaceutical industry, regulatory authorities, policymakers and patient advocacy groups to improve cancer treatment.
CORE VALUES & PRINCIPLES
HISTORY
Established in 2001 as the Biotherapy Development Association (BDA), the initial focus of the organisation was immunotherapy, proven to be a visionary force in the cancer drug development field.
In 2013, it launched the ACCELERATE platform to improve outcomes for children and adolescents with cancer. In recognition of the importance of embracing all forms of oncology drug development, the association changed its name to the Cancer Drug Development Forum (CDDF) in 2014.